ReviewJournal of proteome research2026
A Selective History of Protein Sequencing and the Impact of Donald F. Hunt on Protein Sequencing by Tandem Mass Spectrometry.
Review in Journal of proteome research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
This review is a selective history of protein sequencing through the year 2000, intended to illuminate just how challenging it was to establish the methods that enabled protein analysis, especially protein analysis by mass spectrometry. My goal is to provide context to the development and impact of mass spectrometry-based methods on protein sequencing over the last 75 years and to highlight the significant research critical to the development of protein sequencing methods. Because the chemistry of proteins is so diverse, an easy "one size fits all" protein sequencing method (such as the methods available for sequencing DNA) was not feasible. The original protein sequencing methods pursued by Sanger, Du Vigneaud, and Edman relied on chemical methods to decipher amino acid sequences, but in 1959 Klaus Biemann used mass spectrometry to analyze di- and tripeptides, thus introducing the use of mass spectrometry to the protein sequencing field. Donald F. Hunt of the University of Virginia was the first to develop tandem mass spectrometry-based methods for sequencing peptides and proteins, and many of his methods are in use to this day. Hunt made landmark contributions in mass spectrometry technology development and applied his tandem mass spectrometry methods widely across biology, particularly in the field of immunology. The aim of this review is to provide a historical context for Hunt's contributions (as well as other mass spectrometrists!) to protein sequencing and proteomics and to honor Dr. Hunt's contributions upon his retirement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.